Khadija Ismail1,2, Lisa Nussbaum3, Paola Sebastiani3, Stacy Andersen4, Thomas Perls4, Nir Barzilai1,2, Sofiya Milman1,2. 1. Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York. 2. Institute for Aging Research, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York. 3. Department of Biostatistics, School of Public Health, Boston University, Boston, Massachusetts. 4. Geriatrics Section, Department of Medicine, School of Medicine, Boston University and Boston Medical Center, Boston, Massachusetts.
Abstract
OBJECTIVES: To determine, in a sample of Ashkenazi Jewish aged 95 and older, whether there is a compression of morbidity similar to what has been reported in other cohorts with exceptional longevity. DESIGN: Case-control study. SETTING: Longevity Genes Project (LGP) and New England Centenarian Study (NECS). PARTICIPANTS: LGP (n = 439, mean age 97.8 ± 2.8) and NECS (n = 1,498, mean age 101.4 ± 4.0) participants with exceptional longevity and their respective younger referent cohorts (LGP, n = 696; NECS, n = 302). MEASUREMENTS: Self- and proxy reports of age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, osteoporosis, and stroke. RESULTS: Long-lived individuals from LGP and NECS had later age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, and osteoporosis than their respective younger reference groups. The risk of overall morbidity was lower in participants with exceptional longevity than in younger participants (NECS men: relative risk (RR) = 0.12, women: RR = 0.20; LGP men: RR = 0.18, women: RR = 0.24). The age at which 20% of each of the groups with exceptional longevity experienced specific diseases was between 18 and 24 years later than in the reference groups, stratified according to sex. CONCLUSION: The similar extension of health span and compression of morbidity seen in NECS and LGP participants with exceptional longevity further validates the utility of these rare individuals for the study of factors that delay or prevent a broad spectrum of diseases otherwise associated with mortality and disability.
OBJECTIVES: To determine, in a sample of Ashkenazi Jewish aged 95 and older, whether there is a compression of morbidity similar to what has been reported in other cohorts with exceptional longevity. DESIGN: Case-control study. SETTING: Longevity Genes Project (LGP) and New England Centenarian Study (NECS). PARTICIPANTS: LGP (n = 439, mean age 97.8 ± 2.8) and NECS (n = 1,498, mean age 101.4 ± 4.0) participants with exceptional longevity and their respective younger referent cohorts (LGP, n = 696; NECS, n = 302). MEASUREMENTS: Self- and proxy reports of age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, osteoporosis, and stroke. RESULTS: Long-lived individuals from LGP and NECS had later age of onset of cancer, cardiovascular disease, diabetes mellitus, hypertension, and osteoporosis than their respective younger reference groups. The risk of overall morbidity was lower in participants with exceptional longevity than in younger participants (NECS men: relative risk (RR) = 0.12, women: RR = 0.20; LGP men: RR = 0.18, women: RR = 0.24). The age at which 20% of each of the groups with exceptional longevity experienced specific diseases was between 18 and 24 years later than in the reference groups, stratified according to sex. CONCLUSION: The similar extension of health span and compression of morbidity seen in NECS and LGP participants with exceptional longevity further validates the utility of these rare individuals for the study of factors that delay or prevent a broad spectrum of diseases otherwise associated with mortality and disability.
Authors: Yun Freudenberg-Hua; Jan Freudenberg; Vladimir Vacic; Avinash Abhyankar; Anne-Katrin Emde; Danny Ben-Avraham; Nir Barzilai; Dayna Oschwald; Erika Christen; Jeremy Koppel; Blaine Greenwald; Robert B Darnell; Soren Germer; Gil Atzmon; Peter Davies Journal: Mol Genet Genomic Med Date: 2014-06-15 Impact factor: 2.183
Authors: Zhengdong D Zhang; Sofiya Milman; Jhih-Rong Lin; Shayne Wierbowski; Haiyuan Yu; Nir Barzilai; Vera Gorbunova; Warren C Ladiges; Laura J Niedernhofer; Yousin Suh; Paul D Robbins; Jan Vijg Journal: Nat Metab Date: 2020-07-27
Authors: Raya Elfadel Kheirbek; Ali Fokar; Nawar Shara; Leakie K Bell-Wilson; Hans J Moore; Edwin Olsen; Marc R Blackman; Maria D Llorente Journal: J Am Geriatr Soc Date: 2017-04-19 Impact factor: 5.562
Authors: Sarah Marone; Katherine Bloore; Paola Sebastiani; Christopher Flynn; Brittany Leonard; Kelsey Whitaker; Marilyn Mostowy; Thomas T Perls; Stacy L Andersen Journal: J Gerontol B Psychol Sci Soc Sci Date: 2020-01-14 Impact factor: 4.077
Authors: Aladdin H Shadyab; JoAnn E Manson; Wenjun Li; Margery Gass; Robert L Brunner; Michelle J Naughton; Brad Cannell; Barbara V Howard; Andrea Z LaCroix Journal: Age Ageing Date: 2018-11-01 Impact factor: 10.668
Authors: Raya Elfadel Kheirbek; Ali Fokar; Hans J Moore; Nawar Shara; Rami Doukky; Ross D Fletcher Journal: Clin Cardiol Date: 2018-05-12 Impact factor: 2.882